Survival Analysis after Hepatectomy for Hepatocellular Carcinoma: A Retrospective Cohort Study
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- ITMCTR2200006003
- Lead Sponsor
- Zhongshan Hospital Affiliated to Fudan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
? It meets the diagnostic criteria of HCC and the characteristics of TCM syndrome differentiation and treatment; ? The general health status (PS) score is 0-2; ? Child Pugh is classified as a or B; ? The clinical stages of liver cancer in China (CNLC) are stage IA, stage IB, stage IIA and stage IIB; ? Radical treatment (Hepatectomy) after diagnosis of HCC is treatment measures and entered between December 2014 and may 2015; ? Postoperative TCM treatment mainly takes traditional Chinese medicine decoction (or granule); ? Postoperative medical treatment mainly included general medical treatment, transcatheter hepatic arterial chemoembolization (TACE) and systematic treatment; ? The original case data are relatively complete.
? Those who do not have the conditions for radical treatment; ? Patients with serious adverse reactions after traditional Chinese medicine and traditional Chinese medicine treatment; ? Patients with invasion or extrahepatic metastasis; ? Severe basic liver disease or combined with other serious basic diseases (including other malignant tumors); ? Serious lack of original case data.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DFS;OS;
- Secondary Outcome Measures
Name Time Method